

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.15937926 |
| 2 | muscle filament sliding (GO:0030049) | 6.15937926 |
| 3 | sarcomere organization (GO:0045214) | 5.87620256 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 5.59897037 |
| 5 | actin-mediated cell contraction (GO:0070252) | 5.12533841 |
| 6 | plasma membrane repair (GO:0001778) | 5.08611538 |
| 7 | response to muscle activity (GO:0014850) | 5.00599923 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.90660683 |
| 9 | myofibril assembly (GO:0030239) | 4.83487126 |
| 10 | cardiac myofibril assembly (GO:0055003) | 4.75443039 |
| 11 | carnitine shuttle (GO:0006853) | 4.64873687 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.61955369 |
| 13 | skeletal muscle fiber development (GO:0048741) | 4.56181735 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.40730913 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 4.40415058 |
| 16 | lysine catabolic process (GO:0006554) | 4.35518214 |
| 17 | lysine metabolic process (GO:0006553) | 4.35518214 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.30702139 |
| 19 | 2-oxoglutarate metabolic process (GO:0006103) | 4.30138949 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 4.30137831 |
| 21 | creatine metabolic process (GO:0006600) | 4.24207442 |
| 22 | aspartate family amino acid catabolic process (GO:0009068) | 4.23780299 |
| 23 | skeletal muscle contraction (GO:0003009) | 4.19221419 |
| 24 | cardiac muscle contraction (GO:0060048) | 4.04272410 |
| 25 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.99728377 |
| 26 | striated muscle contraction (GO:0006941) | 3.96657198 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.95290365 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 3.95290365 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95190010 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.95190010 |
| 31 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.93198570 |
| 32 | myotube cell development (GO:0014904) | 3.91687475 |
| 33 | actomyosin structure organization (GO:0031032) | 3.89787432 |
| 34 | actin filament-based movement (GO:0030048) | 3.88274598 |
| 35 | response to inactivity (GO:0014854) | 3.84932530 |
| 36 | fatty acid beta-oxidation (GO:0006635) | 3.81355286 |
| 37 | glyoxylate metabolic process (GO:0046487) | 3.79084564 |
| 38 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.78023032 |
| 39 | gluconeogenesis (GO:0006094) | 3.77312850 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.75071931 |
| 41 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.74655320 |
| 42 | muscle system process (GO:0003012) | 3.72559745 |
| 43 | focal adhesion assembly (GO:0048041) | 3.72236574 |
| 44 | cell-substrate adherens junction assembly (GO:0007045) | 3.72236574 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 3.69346970 |
| 46 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.64006210 |
| 47 | cardiac muscle cell development (GO:0055013) | 3.62080321 |
| 48 | regulation of sequestering of triglyceride (GO:0010889) | 3.61437574 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.57611916 |
| 50 | carnitine transmembrane transport (GO:1902603) | 3.57114883 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 3.54042744 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.50651421 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50266355 |
| 54 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.50222461 |
| 55 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.49981290 |
| 56 | hexose biosynthetic process (GO:0019319) | 3.49168944 |
| 57 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47389073 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.45360605 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.45171435 |
| 60 | adherens junction assembly (GO:0034333) | 3.43443980 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 3.43330911 |
| 62 | striated muscle adaptation (GO:0014888) | 3.42820714 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 3.42116203 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.42036527 |
| 65 | fatty acid catabolic process (GO:0009062) | 3.40050227 |
| 66 | desmosome organization (GO:0002934) | 3.39167392 |
| 67 | regulation of fatty acid oxidation (GO:0046320) | 3.38686428 |
| 68 | fatty acid oxidation (GO:0019395) | 3.38667841 |
| 69 | cardiac cell development (GO:0055006) | 3.38437325 |
| 70 | adult heart development (GO:0007512) | 3.38159655 |
| 71 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.38157584 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.38129019 |
| 73 | carnitine transport (GO:0015879) | 3.38129019 |
| 74 | glycogen catabolic process (GO:0005980) | 3.34645982 |
| 75 | lipid oxidation (GO:0034440) | 3.33713134 |
| 76 | negative regulation of cell size (GO:0045792) | 3.33111345 |
| 77 | muscle cell fate commitment (GO:0042693) | 3.33071388 |
| 78 | ethanol oxidation (GO:0006069) | 3.32873586 |
| 79 | muscle cell cellular homeostasis (GO:0046716) | 3.32765962 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 3.32397431 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 3.31102646 |
| 82 | carnitine metabolic process (GO:0009437) | 3.30579024 |
| 83 | positive regulation of fatty acid oxidation (GO:0046321) | 3.25325368 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.23582901 |
| 85 | aromatic amino acid family catabolic process (GO:0009074) | 3.23303457 |
| 86 | muscle fiber development (GO:0048747) | 3.22533069 |
| 87 | monosaccharide biosynthetic process (GO:0046364) | 3.21816670 |
| 88 | regulation of the force of heart contraction (GO:0002026) | 3.21786863 |
| 89 | cardiac muscle hypertrophy (GO:0003300) | 3.21395572 |
| 90 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.20678804 |
| 91 | polysaccharide catabolic process (GO:0000272) | 3.19034611 |
| 92 | monocarboxylic acid catabolic process (GO:0072329) | 3.15008265 |
| 93 | positive regulation of myotube differentiation (GO:0010831) | 3.14421178 |
| 94 | glucan catabolic process (GO:0009251) | 3.14375148 |
| 95 | skeletal muscle adaptation (GO:0043501) | 3.13690887 |
| 96 | skeletal muscle tissue development (GO:0007519) | 3.13125877 |
| 97 | regulation of cell communication by electrical coupling (GO:0010649) | 3.13021569 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.12506066 |
| 99 | striated muscle hypertrophy (GO:0014897) | 3.12339784 |
| 100 | cell-substrate junction assembly (GO:0007044) | 3.12327518 |
| 101 | striated muscle atrophy (GO:0014891) | 3.07304578 |
| 102 | NADH metabolic process (GO:0006734) | 3.07200279 |
| 103 | muscle hypertrophy (GO:0014896) | 3.06463176 |
| 104 | sulfur amino acid catabolic process (GO:0000098) | 3.05903677 |
| 105 | regulation of coenzyme metabolic process (GO:0051196) | 3.05381622 |
| 106 | regulation of cofactor metabolic process (GO:0051193) | 3.05381622 |
| 107 | ketone body metabolic process (GO:1902224) | 3.04325626 |
| 108 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.02636031 |
| 109 | muscle tissue morphogenesis (GO:0060415) | 3.02358295 |
| 110 | muscle contraction (GO:0006936) | 3.01969176 |
| 111 | bile acid biosynthetic process (GO:0006699) | 3.01774801 |
| 112 | branched-chain amino acid metabolic process (GO:0009081) | 2.99421997 |
| 113 | heart trabecula formation (GO:0060347) | 2.99065637 |
| 114 | biotin metabolic process (GO:0006768) | 2.98970584 |
| 115 | regulation of striated muscle contraction (GO:0006942) | 2.98855891 |
| 116 | glycogen metabolic process (GO:0005977) | 2.96894989 |
| 117 | alpha-amino acid catabolic process (GO:1901606) | 2.95102578 |
| 118 | regulation of membrane repolarization (GO:0060306) | 2.95054193 |
| 119 | negative regulation of fibrinolysis (GO:0051918) | 2.95015958 |
| 120 | valine metabolic process (GO:0006573) | 2.94426891 |
| 121 | striated muscle cell development (GO:0055002) | 2.93662869 |
| 122 | glucan biosynthetic process (GO:0009250) | 2.93553538 |
| 123 | glycogen biosynthetic process (GO:0005978) | 2.93553538 |
| 124 | response to mercury ion (GO:0046689) | 2.93177774 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.92079433 |
| 126 | serine family amino acid catabolic process (GO:0009071) | 2.88489751 |
| 127 | cellular polysaccharide catabolic process (GO:0044247) | 2.88369493 |
| 128 | fructose metabolic process (GO:0006000) | 2.88140828 |
| 129 | cellular glucan metabolic process (GO:0006073) | 2.87806395 |
| 130 | glucan metabolic process (GO:0044042) | 2.87806395 |
| 131 | glycolytic process (GO:0006096) | 2.87665346 |
| 132 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.86164050 |
| 133 | myoblast fusion (GO:0007520) | 2.85852007 |
| 134 | muscle organ development (GO:0007517) | 2.80686545 |
| 135 | muscle atrophy (GO:0014889) | 2.79824707 |
| 136 | muscle structure development (GO:0061061) | 2.78726608 |
| 137 | proline biosynthetic process (GO:0006561) | 2.76356128 |
| 138 | epithelial cell-cell adhesion (GO:0090136) | 2.72892223 |
| 139 | cardiac muscle adaptation (GO:0014887) | 2.72354335 |
| 140 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.72354335 |
| 141 | muscle hypertrophy in response to stress (GO:0003299) | 2.72354335 |
| 142 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.72164848 |
| 143 | hemidesmosome assembly (GO:0031581) | 2.70551677 |
| 144 | muscle adaptation (GO:0043500) | 2.70428692 |
| 145 | 4-hydroxyproline metabolic process (GO:0019471) | 2.70180502 |
| 146 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.69369887 |
| 147 | negative regulation of protein localization to cell surface (GO:2000009) | 2.68516545 |
| 148 | muscle cell development (GO:0055001) | 2.61857232 |
| 149 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.58838290 |
| 150 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.57787083 |
| 151 | IMP metabolic process (GO:0046040) | 2.57524469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.03396512 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.88918270 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.76783101 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.33137631 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.95413006 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.41402213 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15956942 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.11909316 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66604689 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.60630877 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.51787454 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30117592 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.29446317 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.28439034 |
| 15 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.26355663 |
| 16 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.26355663 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14514991 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.09570002 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08189400 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07296379 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.02658721 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96952898 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89394108 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79716198 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74560865 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68784136 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65355452 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63280419 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50416145 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.49784658 |
| 31 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48800919 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47135360 |
| 33 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.46160764 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43604843 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42284090 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41550240 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40496752 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38992585 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38759056 |
| 40 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.38101996 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38092917 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37723989 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37418847 |
| 44 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36970756 |
| 45 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.35540175 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.35341951 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35155406 |
| 48 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.33124140 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32990064 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32253999 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32182946 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30831419 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28517561 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27713405 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27276529 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26799106 |
| 57 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.26366709 |
| 58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25618377 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25305214 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23675214 |
| 61 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23428309 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21544745 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21160980 |
| 64 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.20891954 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19761058 |
| 66 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17053512 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16952375 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16638295 |
| 69 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15494775 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15369442 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14662193 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14248786 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13916177 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.13382845 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12431940 |
| 76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10675301 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09804246 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08680379 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08384349 |
| 80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07536141 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07375477 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07049557 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06453482 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05586276 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04965716 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04690841 |
| 87 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02672694 |
| 88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02652405 |
| 89 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02173117 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01736093 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99101238 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99085231 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98269008 |
| 94 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.97747850 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94170640 |
| 96 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.93528376 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93414902 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92780938 |
| 99 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92068324 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90082352 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90082352 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88609486 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86377603 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86006664 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85016092 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84417978 |
| 107 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.84009194 |
| 108 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82719698 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82470540 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81769363 |
| 111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.81577803 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81556322 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81346168 |
| 114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80606826 |
| 115 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80371731 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80371718 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80032093 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79933145 |
| 119 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79675276 |
| 120 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79206175 |
| 121 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79120270 |
| 122 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78849137 |
| 123 | * P68_20966046_ChIP-Seq_HELA_Human | 0.78815946 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78543580 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78065350 |
| 126 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77747925 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77180508 |
| 128 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.75783563 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75516097 |
| 130 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74955245 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.74439630 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74042967 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73572070 |
| 134 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.71894001 |
| 135 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.71492055 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71416377 |
| 137 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.71332641 |
| 138 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.71332641 |
| 139 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.70193464 |
| 140 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69162247 |
| 141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.68871822 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.67909147 |
| 143 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.67551112 |
| 144 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67290832 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67140518 |
| 146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66587507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.16604214 |
| 2 | MP0000751_myopathy | 4.57344032 |
| 3 | MP0003646_muscle_fatigue | 4.50701223 |
| 4 | MP0000749_muscle_degeneration | 3.99072404 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.45239668 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.37241378 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.33982703 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.23857164 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.93549480 |
| 10 | MP0005330_cardiomyopathy | 2.92788706 |
| 11 | MP0005360_urolithiasis | 2.83974228 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.79495364 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.78457657 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.76268097 |
| 15 | MP0004130_abnormal_muscle_cell | 2.66576709 |
| 16 | MP0000747_muscle_weakness | 2.60372241 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.51300410 |
| 18 | MP0005365_abnormal_bile_salt | 2.47837152 |
| 19 | MP0002269_muscular_atrophy | 2.47551552 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.43145750 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.33516511 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.17289360 |
| 23 | MP0002972_abnormal_cardiac_muscle | 2.10384549 |
| 24 | MP0005369_muscle_phenotype | 2.05411730 |
| 25 | MP0010030_abnormal_orbit_morphology | 2.00438815 |
| 26 | MP0009840_abnormal_foam_cell | 1.96790388 |
| 27 | MP0005083_abnormal_biliary_tract | 1.94364958 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.88748586 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85215310 |
| 30 | MP0010630_abnormal_cardiac_muscle | 1.82710620 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.71468428 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.71468428 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.71201862 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.71027709 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.70095303 |
| 36 | MP0003252_abnormal_bile_duct | 1.67963300 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.63696302 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.59879984 |
| 39 | MP0001661_extended_life_span | 1.59574789 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.58456111 |
| 41 | MP0006138_congestive_heart_failure | 1.55163179 |
| 42 | MP0004233_abnormal_muscle_weight | 1.52874039 |
| 43 | MP0003195_calcinosis | 1.51819539 |
| 44 | MP0004484_altered_response_of | 1.48098811 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.43739404 |
| 46 | MP0003941_abnormal_skin_development | 1.43687895 |
| 47 | MP0005332_abnormal_amino_acid | 1.42106816 |
| 48 | MP0005670_abnormal_white_adipose | 1.38346534 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.35678159 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.28617482 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27831619 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.26262394 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.22055763 |
| 54 | MP0004085_abnormal_heartbeat | 1.20961244 |
| 55 | MP0005451_abnormal_body_composition | 1.16503548 |
| 56 | MP0005375_adipose_tissue_phenotype | 1.11523269 |
| 57 | MP0002971_abnormal_brown_adipose | 1.10448467 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.09825960 |
| 59 | MP0000733_abnormal_muscle_development | 1.09609517 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.07395520 |
| 61 | MP0004858_abnormal_nervous_system | 1.04373682 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.03280510 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.03054944 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 0.99906125 |
| 65 | MP0001849_ear_inflammation | 0.99224369 |
| 66 | MP0009672_abnormal_birth_weight | 0.97039286 |
| 67 | MP0005275_abnormal_skin_tensile | 0.96906469 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 0.94350605 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92716069 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.92346045 |
| 71 | MP0005266_abnormal_metabolism | 0.91741218 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.89370456 |
| 73 | MP0003279_aneurysm | 0.89099427 |
| 74 | MP0000609_abnormal_liver_physiology | 0.87172639 |
| 75 | MP0001346_abnormal_lacrimal_gland | 0.85822285 |
| 76 | MP0000467_abnormal_esophagus_morphology | 0.85658478 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.85593391 |
| 78 | MP0001299_abnormal_eye_distance/ | 0.85403486 |
| 79 | MP0002060_abnormal_skin_morphology | 0.83339636 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.82979834 |
| 81 | MP0003828_pulmonary_edema | 0.82156511 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.81714771 |
| 83 | MP0005501_abnormal_skin_physiology | 0.80350634 |
| 84 | MP0005257_abnormal_intraocular_pressure | 0.79583027 |
| 85 | MP0004043_abnormal_pH_regulation | 0.76330996 |
| 86 | MP0000537_abnormal_urethra_morphology | 0.75126599 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.73962470 |
| 88 | MP0003123_paternal_imprinting | 0.73945268 |
| 89 | MP0004270_analgesia | 0.73879648 |
| 90 | MP0003329_amyloid_beta_deposits | 0.73562925 |
| 91 | MP0000566_synostosis | 0.73496117 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.73282143 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.72959106 |
| 94 | MP0000266_abnormal_heart_morphology | 0.70744963 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.67469670 |
| 96 | MP0005165_increased_susceptibility_to | 0.66770008 |
| 97 | MP0000343_altered_response_to | 0.66502423 |
| 98 | MP0004510_myositis | 0.65618254 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.65459881 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.65252800 |
| 101 | MP0005409_darkened_coat_color | 0.64323516 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.64276783 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.63975344 |
| 104 | MP0008260_abnormal_autophagy | 0.63655222 |
| 105 | MP0000579_abnormal_nail_morphology | 0.62795637 |
| 106 | MP0002128_abnormal_blood_circulation | 0.59114429 |
| 107 | MP0001730_embryonic_growth_arrest | 0.57261670 |
| 108 | MP0002796_impaired_skin_barrier | 0.56753946 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.56702777 |
| 110 | MP0009250_abnormal_appendicular_skeleto | 0.53576494 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.53300290 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.52823441 |
| 113 | MP0005334_abnormal_fat_pad | 0.52550467 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.52416102 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.52402545 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.52156346 |
| 117 | MP0003385_abnormal_body_wall | 0.51512360 |
| 118 | MP0003984_embryonic_growth_retardation | 0.51456765 |
| 119 | MP0002114_abnormal_axial_skeleton | 0.50153669 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.49650558 |
| 121 | MP0002088_abnormal_embryonic_growth/wei | 0.48239822 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.48008096 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.47621560 |
| 124 | MP0004197_abnormal_fetal_growth/weight/ | 0.46104004 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.45531299 |
| 126 | MP0004272_abnormal_basement_membrane | 0.45510566 |
| 127 | MP0003942_abnormal_urinary_system | 0.45328648 |
| 128 | MP0005187_abnormal_penis_morphology | 0.44540812 |
| 129 | MP0005376_homeostasis/metabolism_phenot | 0.43540919 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.43220252 |
| 131 | MP0003690_abnormal_glial_cell | 0.43177365 |
| 132 | MP0005535_abnormal_body_temperature | 0.43151945 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.41847839 |
| 134 | MP0004019_abnormal_vitamin_homeostasis | 0.39339433 |
| 135 | MP0003011_delayed_dark_adaptation | 0.38543872 |
| 136 | MP0000604_amyloidosis | 0.38380313 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.36634086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.27562031 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.77659352 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.48221971 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.44712157 |
| 5 | Muscle fiber splitting (HP:0003555) | 5.30945634 |
| 6 | Sudden death (HP:0001699) | 5.24353555 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 5.23256528 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.07927192 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.04121935 |
| 10 | Myoglobinuria (HP:0002913) | 4.73421218 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 4.62622385 |
| 12 | Nemaline bodies (HP:0003798) | 4.51996572 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.40227598 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.39777436 |
| 15 | Ventricular tachycardia (HP:0004756) | 4.28212334 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.12223512 |
| 17 | Increased connective tissue (HP:0009025) | 4.09954013 |
| 18 | Difficulty running (HP:0009046) | 4.09321994 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.94202954 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.59647992 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.45239895 |
| 22 | Subaortic stenosis (HP:0001682) | 3.45239895 |
| 23 | Distal arthrogryposis (HP:0005684) | 3.41877804 |
| 24 | Myotonia (HP:0002486) | 3.32187295 |
| 25 | Round ear (HP:0100830) | 3.32117641 |
| 26 | Lipoatrophy (HP:0100578) | 3.31291603 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.24514846 |
| 28 | Muscle stiffness (HP:0003552) | 3.21949644 |
| 29 | Atrial fibrillation (HP:0005110) | 3.21720782 |
| 30 | Myopathic facies (HP:0002058) | 3.02039678 |
| 31 | Difficulty climbing stairs (HP:0003551) | 2.99653937 |
| 32 | Dilated cardiomyopathy (HP:0001644) | 2.99631311 |
| 33 | Ketosis (HP:0001946) | 2.97572585 |
| 34 | Bundle branch block (HP:0011710) | 2.95534787 |
| 35 | Primary atrial arrhythmia (HP:0001692) | 2.94884169 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.92822084 |
| 37 | Ketoacidosis (HP:0001993) | 2.92003358 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91965219 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.90211901 |
| 40 | Xanthomatosis (HP:0000991) | 2.87386752 |
| 41 | Palpitations (HP:0001962) | 2.84254969 |
| 42 | Deep venous thrombosis (HP:0002625) | 2.84250338 |
| 43 | Supraventricular tachycardia (HP:0004755) | 2.82301737 |
| 44 | Progressive muscle weakness (HP:0003323) | 2.81609017 |
| 45 | Supraventricular arrhythmia (HP:0005115) | 2.77550105 |
| 46 | Heart block (HP:0012722) | 2.76618755 |
| 47 | Hyperammonemia (HP:0001987) | 2.76326128 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.76042509 |
| 49 | Syncope (HP:0001279) | 2.74825515 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74494953 |
| 51 | Atrioventricular block (HP:0001678) | 2.72355635 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.68100111 |
| 53 | Abnormal atrioventricular conduction (HP:0005150) | 2.67508928 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.66336625 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 2.65387031 |
| 56 | Bulbar palsy (HP:0001283) | 2.63570515 |
| 57 | Ventricular arrhythmia (HP:0004308) | 2.61599755 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.59580929 |
| 59 | Neck muscle weakness (HP:0000467) | 2.58859311 |
| 60 | Hyperglycinuria (HP:0003108) | 2.48361912 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43541902 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.42568303 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.42105632 |
| 64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42105632 |
| 65 | Lower limb amyotrophy (HP:0007210) | 2.41066310 |
| 66 | Cholelithiasis (HP:0001081) | 2.40727936 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.38371185 |
| 68 | Hypolipoproteinemia (HP:0010981) | 2.37378682 |
| 69 | Prolonged QT interval (HP:0001657) | 2.35005718 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.34987858 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33492860 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.33492860 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.24044272 |
| 74 | Limb-girdle muscle atrophy (HP:0003797) | 2.23150034 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.23063590 |
| 76 | Absent phalangeal crease (HP:0006109) | 2.23038483 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21927348 |
| 78 | Cerebral edema (HP:0002181) | 2.20125854 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.16494123 |
| 80 | Calcaneovalgus deformity (HP:0001848) | 2.14592595 |
| 81 | Hyperglycinemia (HP:0002154) | 2.14071627 |
| 82 | Abnormality of the foot musculature (HP:0001436) | 2.13768999 |
| 83 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12898305 |
| 84 | Popliteal pterygium (HP:0009756) | 2.09631969 |
| 85 | Rimmed vacuoles (HP:0003805) | 2.09395219 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 2.08850663 |
| 87 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06336480 |
| 88 | Gowers sign (HP:0003391) | 2.03807789 |
| 89 | Slender build (HP:0001533) | 2.02650840 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 2.01904332 |
| 91 | Gout (HP:0001997) | 2.01004571 |
| 92 | Fatigable weakness (HP:0003473) | 2.00033680 |
| 93 | Abnormality of the neuromuscular junction (HP:0003398) | 2.00033680 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 1.97668863 |
| 95 | Fetal akinesia sequence (HP:0001989) | 1.96386079 |
| 96 | Deformed tarsal bones (HP:0008119) | 1.94103107 |
| 97 | Scapular winging (HP:0003691) | 1.93903911 |
| 98 | Hypoplastic ischia (HP:0003175) | 1.92249029 |
| 99 | Generalized muscle weakness (HP:0003324) | 1.91659200 |
| 100 | Ventricular fibrillation (HP:0001663) | 1.91640579 |
| 101 | Hepatic necrosis (HP:0002605) | 1.91591306 |
| 102 | Metatarsus adductus (HP:0001840) | 1.91085571 |
| 103 | Hypobetalipoproteinemia (HP:0003563) | 1.90315847 |
| 104 | Metabolic acidosis (HP:0001942) | 1.89904683 |
| 105 | Malignant hyperthermia (HP:0002047) | 1.89904287 |
| 106 | Trismus (HP:0000211) | 1.89683145 |
| 107 | Muscular dystrophy (HP:0003560) | 1.87984422 |
| 108 | Hip contracture (HP:0003273) | 1.87879739 |
| 109 | Frequent falls (HP:0002359) | 1.84838028 |
| 110 | Achilles tendon contracture (HP:0001771) | 1.84554814 |
| 111 | Weak cry (HP:0001612) | 1.83390260 |
| 112 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79706957 |
| 113 | Generalized amyotrophy (HP:0003700) | 1.79377345 |
| 114 | Palmoplantar keratoderma (HP:0000982) | 1.79204292 |
| 115 | Abnormal finger flexion creases (HP:0006143) | 1.78947849 |
| 116 | Testicular atrophy (HP:0000029) | 1.78444057 |
| 117 | Acute encephalopathy (HP:0006846) | 1.78155651 |
| 118 | Spinal rigidity (HP:0003306) | 1.78146531 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.77377948 |
| 120 | Waddling gait (HP:0002515) | 1.77212680 |
| 121 | Protrusio acetabuli (HP:0003179) | 1.77170791 |
| 122 | Pterygium (HP:0001059) | 1.76564449 |
| 123 | Breech presentation (HP:0001623) | 1.73629914 |
| 124 | Premature rupture of membranes (HP:0001788) | 1.72137446 |
| 125 | Proximal amyotrophy (HP:0007126) | 1.71477963 |
| 126 | Limb-girdle muscle weakness (HP:0003325) | 1.67190450 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 1.64626094 |
| 128 | Back pain (HP:0003418) | 1.61462770 |
| 129 | Stridor (HP:0010307) | 1.60909057 |
| 130 | Hyperkalemia (HP:0002153) | 1.58256265 |
| 131 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.58106484 |
| 132 | Pelvic girdle muscle weakness (HP:0003749) | 1.57149167 |
| 133 | Adducted thumb (HP:0001181) | 1.53305336 |
| 134 | Congenital hip dislocation (HP:0001374) | 1.47094784 |
| 135 | Dysmetric saccades (HP:0000641) | 1.45922808 |
| 136 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.44864018 |
| 137 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.44864018 |
| 138 | Thin ribs (HP:0000883) | 1.44269576 |
| 139 | Limited hip movement (HP:0008800) | 1.43166626 |
| 140 | Exercise intolerance (HP:0003546) | 1.39127012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.60697514 |
| 2 | OBSCN | 5.36069990 |
| 3 | PHKG2 | 4.16659433 |
| 4 | PHKG1 | 4.16659433 |
| 5 | BCKDK | 3.68781462 |
| 6 | TRIB3 | 3.41693779 |
| 7 | EEF2K | 2.61601445 |
| 8 | LMTK2 | 2.48492571 |
| 9 | PDK3 | 2.46637232 |
| 10 | PDK4 | 2.46637232 |
| 11 | EPHA2 | 2.39466137 |
| 12 | PKN2 | 2.23416720 |
| 13 | PINK1 | 2.20687933 |
| 14 | PIK3CA | 2.18042063 |
| 15 | DMPK | 2.06592374 |
| 16 | PIK3CG | 1.99982772 |
| 17 | SIK1 | 1.91813939 |
| 18 | MUSK | 1.84783773 |
| 19 | MYLK | 1.83796766 |
| 20 | NEK1 | 1.81004060 |
| 21 | SMG1 | 1.69610382 |
| 22 | PDK2 | 1.63846800 |
| 23 | MAP3K7 | 1.57971800 |
| 24 | NME2 | 1.43363336 |
| 25 | MAPK12 | 1.41718149 |
| 26 | RPS6KB2 | 1.36587649 |
| 27 | MAP2K3 | 1.34060663 |
| 28 | EPHB1 | 1.33424458 |
| 29 | LIMK1 | 1.33110019 |
| 30 | RIPK1 | 1.31736443 |
| 31 | TESK1 | 1.19588247 |
| 32 | NME1 | 1.19575238 |
| 33 | PAK3 | 1.16779791 |
| 34 | ERN1 | 1.11760311 |
| 35 | IRAK3 | 1.09632954 |
| 36 | PRKD1 | 1.04576859 |
| 37 | TIE1 | 1.04429794 |
| 38 | MAP2K4 | 1.01806124 |
| 39 | FGFR4 | 1.00645068 |
| 40 | CAMK2D | 0.97551111 |
| 41 | PKN1 | 0.95127072 |
| 42 | PBK | 0.93846677 |
| 43 | MAP3K3 | 0.93213687 |
| 44 | LATS1 | 0.92943608 |
| 45 | ARAF | 0.89698415 |
| 46 | PRKAA2 | 0.89604766 |
| 47 | INSRR | 0.88709601 |
| 48 | CAMK2G | 0.86979105 |
| 49 | PAK4 | 0.86917378 |
| 50 | STK38L | 0.86719697 |
| 51 | ILK | 0.85585443 |
| 52 | PTK6 | 0.84531681 |
| 53 | PRKAA1 | 0.83574856 |
| 54 | MAPKAPK3 | 0.83100239 |
| 55 | SCYL2 | 0.82838928 |
| 56 | PDGFRA | 0.80215435 |
| 57 | ROCK1 | 0.77769903 |
| 58 | CDK12 | 0.75193645 |
| 59 | LATS2 | 0.72622432 |
| 60 | STK24 | 0.70754784 |
| 61 | WNK4 | 0.69109719 |
| 62 | MOS | 0.67018591 |
| 63 | STK39 | 0.64912045 |
| 64 | ICK | 0.63236645 |
| 65 | PRPF4B | 0.62871275 |
| 66 | STK38 | 0.62200806 |
| 67 | DAPK3 | 0.61767969 |
| 68 | CCNB1 | 0.61027021 |
| 69 | MAP3K10 | 0.59703258 |
| 70 | MAPK11 | 0.58952352 |
| 71 | ROCK2 | 0.58902299 |
| 72 | NEK9 | 0.58413268 |
| 73 | TAOK1 | 0.57577109 |
| 74 | TAOK2 | 0.56892747 |
| 75 | FGFR2 | 0.54965198 |
| 76 | FER | 0.53994206 |
| 77 | TRPM7 | 0.53467132 |
| 78 | MAP3K5 | 0.52709963 |
| 79 | PDPK1 | 0.51956094 |
| 80 | CAMK2B | 0.51630638 |
| 81 | AKT2 | 0.50444475 |
| 82 | MAP3K6 | 0.50210227 |
| 83 | CAMK4 | 0.48472421 |
| 84 | MET | 0.48126073 |
| 85 | PRKACB | 0.47766852 |
| 86 | MAP2K6 | 0.46814436 |
| 87 | CDC42BPA | 0.46809241 |
| 88 | CAMK2A | 0.46468129 |
| 89 | EPHB2 | 0.45919989 |
| 90 | WNK1 | 0.44967012 |
| 91 | MAP2K1 | 0.44902175 |
| 92 | MAPK7 | 0.44520348 |
| 93 | RPS6KA2 | 0.44141254 |
| 94 | NTRK1 | 0.43800998 |
| 95 | RPS6KC1 | 0.43677274 |
| 96 | RPS6KL1 | 0.43677274 |
| 97 | DDR2 | 0.43504288 |
| 98 | MST1R | 0.42744230 |
| 99 | BRAF | 0.42340019 |
| 100 | PAK6 | 0.41165382 |
| 101 | MTOR | 0.40370882 |
| 102 | CDK7 | 0.40133527 |
| 103 | VRK2 | 0.39594500 |
| 104 | PTK2 | 0.39389864 |
| 105 | MAP2K2 | 0.38920571 |
| 106 | DAPK2 | 0.38137911 |
| 107 | DYRK1B | 0.37663470 |
| 108 | PRKACG | 0.37348081 |
| 109 | MAP3K9 | 0.37291731 |
| 110 | CDK8 | 0.37033905 |
| 111 | PRKD3 | 0.36611283 |
| 112 | MAP3K13 | 0.33507887 |
| 113 | PRKACA | 0.33412055 |
| 114 | RPS6KA1 | 0.32073620 |
| 115 | PRKG2 | 0.32018768 |
| 116 | PTK2B | 0.31850621 |
| 117 | ERBB4 | 0.31724789 |
| 118 | RET | 0.31429915 |
| 119 | FLT3 | 0.30696461 |
| 120 | MAP3K1 | 0.30198316 |
| 121 | MAPK4 | 0.29987371 |
| 122 | SGK3 | 0.29114504 |
| 123 | ZAK | 0.28720510 |
| 124 | PIM2 | 0.28088421 |
| 125 | KSR2 | 0.28082327 |
| 126 | MAP3K8 | 0.27950689 |
| 127 | BMX | 0.27942440 |
| 128 | SGK494 | 0.27367158 |
| 129 | SGK223 | 0.27367158 |
| 130 | RPS6KA6 | 0.26211082 |
| 131 | PAK2 | 0.25903295 |
| 132 | GRK7 | 0.25084087 |
| 133 | RPS6KB1 | 0.25075485 |
| 134 | PDK1 | 0.24770420 |
| 135 | RPS6KA3 | 0.24683995 |
| 136 | SGK1 | 0.24620968 |
| 137 | AURKA | 0.24618901 |
| 138 | MAP3K11 | 0.24615146 |
| 139 | MAPK10 | 0.24514095 |
| 140 | PRKG1 | 0.24373822 |
| 141 | PRKCE | 0.24281077 |
| 142 | FGFR1 | 0.24208112 |
| 143 | KDR | 0.23756508 |
| 144 | TTK | 0.23500547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.78441040 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.40804893 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.29899933 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11404597 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.09757253 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83829737 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58892786 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55649377 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52636663 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50635925 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.39509843 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17905973 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.10795527 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05933073 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00694737 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.99235394 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.92840619 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.92819753 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.89890447 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87660939 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81794998 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72607000 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72347310 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66792375 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.59251926 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56502819 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53097323 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.51872738 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51313951 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48435690 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33439070 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29870798 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28362175 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28356447 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27437023 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17403872 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.15691806 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.12739419 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.08301330 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06090699 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04288284 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02443700 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01451958 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01165882 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00288330 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98628891 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96618052 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96221392 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95088777 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93833909 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92568337 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91096801 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.88763339 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87342065 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87231802 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87085468 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.85244247 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85171329 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.83480238 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82399891 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78566820 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76208357 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75406031 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74729169 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70630447 |
| 66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67185808 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67141640 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66755325 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65802175 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65420092 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63418438 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.62920481 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.61215835 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61178068 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60427996 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58956324 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58833164 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57312449 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56879839 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53446646 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53283475 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.53233804 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52796714 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52496418 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52037779 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.51605837 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49872569 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49039034 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47195025 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.46319400 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45302966 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43497471 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43091993 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43008677 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42757017 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42668281 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42635695 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41944658 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41890372 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41707317 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.41170406 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41160248 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39425988 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39353310 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37507566 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37137305 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35833206 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34800315 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33870921 |
| 110 | DNA replication_Homo sapiens_hsa03030 | 0.33707147 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33444589 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33173223 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33158659 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32443831 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.31933500 |
| 116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30637251 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30217011 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29268456 |
| 119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28784008 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27582986 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26013349 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25463169 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25002547 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23733962 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23725644 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23358566 |
| 127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23178525 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23176603 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22181386 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21189443 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19442915 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18798894 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17871565 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17009672 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16206530 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15900748 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14517257 |

